Diphosphonates

interleukin 6 ; Homo sapiens







16 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 26445021 Antiresorption implant coatings based on calcium alendronate and octacalcium phosphate deposited by matrix assisted pulsed laser evaporation. 2015 Dec 1 1
2 23837828 Interleukin-6 concentration changes in plasma and saliva in bisphosphonate-related osteonecrosis of the jaws. 2014 Jul 2
3 22864527 Oral mucosa produces cytokines and factors influencing osteoclast activity and endothelial cell proliferation, in patients with osteonecrosis of jaw after treatment with zoledronic acid. 2013 May 2
4 19692118 Biofunctional alendronate-Hydroxyapatite thin films deposited by Matrix Assisted Pulsed Laser Evaporation. 2009 Oct 2
5 17374166 The Interleukin-6 inflammation pathway from cholesterol to aging--role of statins, bisphosphonates and plant polyphenols in aging and age-related diseases. 2007 Mar 20 1
6 15935563 Cholesterol synthesis is the trigger and isoprenoid dependent interleukin-6 mediated inflammation is the common causative factor and therapeutic target for atherosclerotic vascular disease and age-related disorders including osteoporosis and type 2 diabetes. 2005 2
7 10925751 Fibrous dysplasia of bone. 2000 Jun 1
8 10599049 Etidronate inhibits the production of IL-6 by osteoblast-like cells. 1999 Oct 1
9 10620064 Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment. 1999 Dec 1
10 9506876 Bisphosphonates inhibit IL-6 production by human osteoblast-like cells. 1998 1
11 9563797 Enhanced expression of interleukin-6 in bone and serum of metastatic renal cell carcinoma. 1998 Apr 2
12 9922036 The role of bisphosphonates for the treatment of bone disease in multiple myeloma. 1998 Nov 1
13 9135506 Acute effects of pamidronate administration on serum levels of interleukin-6 in advanced solid tumour patients with bone metastases and their possible implications in the immunotherapy of cancer with interleukin-2. 1997 Feb 1
14 9351880 An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates. 1997 Nov 1
15 8833207 Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy. 1996 Feb 1
16 7572320 Interleukin-6 and the acute phase response during treatment of patients with Paget's disease with the nitrogen-containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonate. 1995 Jun 1